BILLERICA, Mass., May 23, 2016 /PRNewswire/ -- Bruker
Corporation (NASDAQ: BRKR) today announced that its shareholders
have elected Dr. Cynthia Friend as a
new member of the Board of Directors, effective May 20, 2016.
Dr. Friend currently serves as Director of the Rowland Institute
at Harvard University. She also
serves as Director of the DoE Energy Frontier Research Center for
Sustainable Catalysis at Harvard.
In 2011-2012, Dr. Friend was the Associate Director of the
SLAC National Accelerator Laboratory. From 2001-2011,
she was the Associate Director of the Materials Research Science
and Engineering Center, from 2004-2007, she was the Chair of the
Chemistry and Chemical Biology Department, and from 2002-2005, she
was Associate Dean of the Faculty of Arts & Sciences, all at
Harvard
University.
Dr. Friend became the Theodore Williams Richards Professor of
Chemistry in 1998 and a Professor of Materials Science in 2002 at
Harvard University. Since joining the
Harvard Department of Chemistry in 1982, she has received numerous
awards for her scientific research, and has served on a number of
research and scientific advisory boards and panels. Dr.
Friend holds a Ph.D. in Chemistry from the University of California, Berkeley.
Frank Laukien, the President and
CEO of Bruker, stated: "It is my great pleasure to welcome Cynthia
to Bruker's Board of Directors. Her experience with science
policy, research priorities and strategy development will be very
valuable to Bruker. In addition, her insights into scientific
trends and emerging applications will help us prioritize and direct
our research and development investments, and grow with new
opportunities and in new markets."
"I am looking forward to serve on the Board of Directors of
Bruker Corporation - a leader in the development of scientific
instrumentation and analytical methods," said Cynthia Friend. "It will be a pleasure to work
with the Bruker team to foster additional innovation in the
future."
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker's high-performance
scientific research instruments and high-value analytical solutions
enable scientists to explore life and materials at molecular,
cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, and in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit: http://www.bruker.com.
Photo - http://photos.prnewswire.com/prnh/20160523/370750
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dr-cynthia-friend-joins-bruker-board-of-directors-300273062.html
SOURCE Bruker Corporation